NEW YORK, Feb. 28 (GenomeWeb News) - Luminex has taken a non-exclusive license from the Massachusetts Institute of Technology to develop and commercialize miRNA assays.
The deal applies to intellectual property developed by MIT, Howard Hughes Medical Institute, Dana-Farber Cancer Institute, and other members of the Broad Institute.
Additional details were not released.